Have a personal or library account? Click to login
The carbohydrate-deficient transferrin as a marker of chronic alcohol consumption and assessment of its usefulness in patients with cardiovascular diseases – a pilot study Cover

The carbohydrate-deficient transferrin as a marker of chronic alcohol consumption and assessment of its usefulness in patients with cardiovascular diseases – a pilot study

Postępy Higieny i Medycyny Doświadczalnej
Volume 77 (2023): Issue 1 (January 2023)
By: Joanna Dominika Waś,  Magdalena Niedolistek,  Dorota Sokołowska,  Joanna Wiśniewska,  Tomasz Zieliński,  Anna Mierzyńska,  Daniel Rabczenko,  Beata Orzechowska,  Dominika Franz,  Ewa Augustynowicz-Kopeć and  Anna Lutyńska  
Open Access
|Oct 2023

References

  1. O’Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, Rao-Melacini P, Zhang X, Pais P, Agapay S, et al. INTERSTROKE investigators. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016; 388: 761–775.
    Search in Google ScholarBack to article
  2. World Health Organization. 2018. Global status report on alcohol and health 2018.
    Search in Google ScholarBack to article
  3. Brotman DJ, Golden SH, Wittstein IS. The cardiovascular toll of stress. Lancet. 2007; 370: 1089–1100.
    Search in Google ScholarBack to article
  4. Mykletun A, Bjerkeset O, Dewey M, Prince M, Overland S, Stewart R. Anxiety, depression, and cause-specific mortality: the HUNT study. Psychosom Med. 2007; 69: 323–331.
    Search in Google ScholarBack to article
  5. Rosengren A, Tibblin G, Wilhelmsen L. Self-perceived psychological stress and incidence of coronary artery disease in middle-aged men. J Am Cardiol. 1991; 68: 1171–1175.
    Search in Google ScholarBack to article
  6. Leong DP, Smyth A, Teo KK, McKee M, Rangarajan S, Pais P, Liu L, Anand SS, Yusuf S. INTERHEART Investigators. Patterns of alcohol consumption and myocardial infarction risk: observations from 52 countries in the INTERHEART case-control study. Circulation. 2014; 130: 390–398.
    Search in Google ScholarBack to article
  7. Wood AM, Kaptoge S, Butterworth AS, Willeit P, Warnakula S, Bolton T, Paige E, Paul DS, Sweeting M, Burgess S, et al. Emerging Risk Factors Collaboration/EPIC-CVD/UK Biobank Alcohol Study Group. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet. 2018; 391: 1513–1523.
    Search in Google ScholarBack to article
  8. Britton A, McKee M. The relation between alcohol and cardiovascular disease in Eastern Europe: explaining the paradox. J Epidemiol Community Health. 2000; 54: 328–332.
    Search in Google ScholarBack to article
  9. Corrao G, Rubbiati L, Bagnardi V, Zambon A, Poikolainen K. Alcohol and coronary heart disease: a meta-analysis. Addiction. 2000; 95: 1505–1523.
    Search in Google ScholarBack to article
  10. Einvik G, Ekeberg Ø, Klemsdal TO, Sandvik L, Hjerkinn EM. Physical distress is associated with cardiovascular events in a high risk population of elderly men. BMC Cardiovasc Disorders. 2009; 9: 14.
    Search in Google ScholarBack to article
  11. Miller PM, Anton RF. Biochemical alcohol screening in primary health care. Addict Behav. 2004; 29: 1427–1437.
    Search in Google ScholarBack to article
  12. Roest AM, Martens EJ, de Jonge P, Denollet J. Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol. 2010; 56: 38–46.
    Search in Google ScholarBack to article
  13. ESC/EASD Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases, 2019. Available at: https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Diabetes-Pre-Diabetes-and-Cardiovascular-Diseases-developed-with-the-EASD
    Search in Google ScholarBack to article
  14. Guzzo-Merello G, Cobo-Marcos M, Gallego-Delgado M, Garcia-Pavia P. Alcoholic cardiomyopathy. World J Cardiol. 2014; 6: 771–781.
    Search in Google ScholarBack to article
  15. Anton RF. Carbohydrate-deficient transferrin for detection and monitoring of sustained heavy drinking. What have we learned? Where do we go from here? Alcohol. 2001; 25: 185–188.
    Search in Google ScholarBack to article
  16. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kühl U, Maisch B, McKenna WJ, et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008; 29: 270–276.
    Search in Google ScholarBack to article
  17. Knott CS, Bell S, Britton A. The stability of baseline-defined categories of alcohol consumption during the adult life-course: a 28-year prospective cohort study. Addiction. 2018; 113: 34–43.
    Search in Google ScholarBack to article
  18. Rehm J, Roerecke M. Cardiovascular effects of alcohol consumption. Trends in Cardiovasc Med. 2017; 27: 534–538.
    Search in Google ScholarBack to article
  19. Roerecke M, Rehm J. Alcohol consumption, drinking patterns, and ischemic heart disease: a narrative review of meta-analyses and a systematic review and meta-analysis of the impact of heavy drinking occasions on risk for moderate drinkers. BMC Med. 2014; 12: 182.
    Search in Google ScholarBack to article
  20. Bergström JP, Helander A. Influence of alcohol use, ethnicity, age, gender, BMI and smoking on the serum transferrin glycoform pattern: Implications for use of carbohydrate-deficient transferrin (CDT) as alcohol biomarker. Clin Chim Acta. 2008; 388: 59–67.
    Search in Google ScholarBack to article
  21. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-Ch, Müller M. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011; 12: 77.
    Search in Google ScholarBack to article
  22. http://www.biomedcentral.com/1471-2105/12/77/
    Search in Google ScholarBack to article
  23. Niemelä O. Biomarkers in alcoholism. Clin Chim Acta. 2007; 377: 39–49.
    Search in Google ScholarBack to article
  24. Golka K, Sondermann R, Reich SE, Wiese A. Carbohydrate-deficient transferrin (CDT) as a biomarker in persons suspected of alcohol abuse. Toxicol Lett. 2004; 151: 235–241.
    Search in Google ScholarBack to article
  25. Rinck D, Frieling H, Freitag A, Hillemacher T, Bayerlein K, Kornhuber J, Bleich S. Combinations of carbohydrate-deficient transferrin, mean corpuscular erythrocyte volume, gamma-glutamyltransferase, homocysteine and folate increase the significance of biological markers in alcohol dependent patients. Drug Alcohol Depend. 2007; 89: 60–65.
    Search in Google ScholarBack to article
  26. Salaspuro M. Carbohydrate-deficient transferrin as compared to other markers of alcoholism: a systematic review. Alcohol. 1999; 19: 261–271.
    Search in Google ScholarBack to article
  27. Chrostek L, Cylwik B, Szmitkowski M, Korcz W. The diagnostic accuracy of carbohydrate-deficient transferrin, sialic acid and commonly used markers of alcohol abuse during abstinence. Clin Chim Acta. 2006; 364: 167–171.
    Search in Google ScholarBack to article
  28. Klatsky AL. Alcohol and cardiovascular mortality: common sense and scientific truth. J Am Coll Cardiol. 2010; 55: 1336–1338.
    Search in Google ScholarBack to article
  29. Xin X., He J., Frontini M.G., Ogden L.G., Motsamai O.I., Whelton P.K.: Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension, 2001; 38: 1112–1117
    Search in Google ScholarBack to article
  30. Weykamp C, Wielders JPM, Helander A, Anton RF, Bianchi V, Jeppsson JO, Siebelder C, Whitfield JB, Schellenberg F. IFCC Working Group on Standardization of Carbohydrate-Deficient Transferrin (WG-CDT). Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: III. Performance of native serum and serum spiked with disialotransferrin proves that harmonization of CDT assays is possible. Clin Chem Lab Med. 2013; 51: 991–996.
    Search in Google ScholarBack to article
  31. Bortolotti F, Sorio D, Bertaso A, Tagliaro F. Analytical and diagnostic aspects of carbohydrate deficient transferrin (CDT): A critical review over years 2007–2017. J Pharm Biomed Anal. 2018; 147: 2–12.
    Search in Google ScholarBack to article
  32. Helander A, Husa A, Jeppsson JO. Improved HPLC method for carbohydrate-deficient transferrin in serum. Clin Chem. 2003; 49: 1881–1890.
    Search in Google ScholarBack to article
DOI: https://doi.org/10.2478/ahem-2023-0010 | Journal eISSN: 1732-2693
Journal RSS Feed
Language: English
Page range: 91 - 98
Submitted on: May 25, 2022
Accepted on: Mar 31, 2023
Published on: Oct 4, 2023
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
carbohydrate deficient transferrin CDT%,
GGT (Gamma-Glutamyl Transferase),
alcohol abuse,
asialotransferrin,
disialotransferrin
Related subjects:
Life sciences,
Molecular biology,
Microbiology and virology,
Medicine,
Basic medical science,
Immunology

© 2023 Joanna Dominika Waś, Magdalena Niedolistek, Dorota Sokołowska, Joanna Wiśniewska, Tomasz Zieliński, Anna Mierzyńska, Daniel Rabczenko, Beata Orzechowska, Dominika Franz, Ewa Augustynowicz-Kopeć, Anna Lutyńska, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 77 (2023): Issue 1 (January 2023)Next article